Detalles de la búsqueda
1.
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer.
N Engl J Med
; 389(22): 2063-2075, 2023 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37861218
2.
Novel dexamethasone-loaded nanomicelles for the intermediate and posterior segment uveitis.
AAPS PharmSciTech
; 15(5): 1238-51, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24895075
3.
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer.
Clin Cancer Res
; 30(8): 1488-1500, 2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38300720
4.
Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study.
J Clin Oncol
; 41(16): 2893-2903, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36689692
5.
Characterization of the Effect of Upadacitinib on the Pharmacokinetics of Bupropion, a Sensitive Cytochrome P450 2B6 Probe Substrate.
Clin Pharmacol Drug Dev
; 10(3): 299-306, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32648334
6.
Exposure-Response Analyses of the Effects of Venetoclax, a Selective BCL-2 Inhibitor, on B-Lymphocyte and Total Lymphocyte Counts in Women with Systemic Lupus Erythematosus.
Clin Pharmacokinet
; 59(3): 335-347, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31541431
7.
Population Pharmacokinetics of the Interleukin-23 Inhibitor Risankizumab in Subjects with Psoriasis and Crohn's Disease: Analyses of Phase I and II Trials.
Clin Pharmacokinet
; 58(3): 375-387, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30123942
8.
Models of Variability and Circadian Rhythm in Heart Rate, Blood Pressure, and QT Interval for Healthy Subjects Who Received Placebo in Phase I Trials.
Clin Transl Sci
; 12(5): 470-480, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31021448
9.
Population Pharmacokinetics of Risankizumab in Healthy Volunteers and Subjects with Moderate to Severe Plaque Psoriasis: Integrated Analyses of Phase I-III Clinical Trials.
Clin Pharmacokinet
; 58(10): 1309-1321, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31054118
10.
Pharmacokinetics of the B-Cell Lymphoma 2 (Bcl-2) Inhibitor Venetoclax in Female Subjects with Systemic Lupus Erythematosus.
Clin Pharmacokinet
; 57(9): 1185-1198, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29333561
11.
Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study.
Lancet Gastroenterol Hepatol
; 3(10): 671-680, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30056030
12.
Application of Exposure-Response Analyses to Establish the Pharmacodynamic Similarity of a Once-Daily Regimen to an Approved Twice-Daily Dosing Regimen for the Treatment of HCV Infection.
AAPS J
; 19(5): 1523-1535, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28685397
13.
Blockade of the High-Affinity Interleukin-2 Receptors with Daclizumab High-Yield Process: Pharmacokinetic/Pharmacodynamic Analysis of Single- and Multiple-Dose Phase I Trials.
Clin Pharmacokinet
; 55(1): 121-30, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26242380
14.
Drug Development and Potential Regulatory Paths for Insulin Biosimilars.
J Diabetes Sci Technol
; 8(1): 14-19, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24876531
15.
Role of OATP-1B1 and/or OATP-1B3 in hepatic disposition of tyrosine kinase inhibitors.
Drug Metabol Drug Interact
; 29(3): 179-90, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24643910
16.
Inhibition of OATP-1B1 and OATP-1B3 by tyrosine kinase inhibitors.
Drug Metabol Drug Interact
; 29(4): 249-59, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24807167
17.
Determination of pazopanib (GW-786034) in mouse plasma and brain tissue by liquid chromatography-tandem mass spectrometry (LC/MS-MS).
J Chromatogr B Analyt Technol Biomed Life Sci
; 901: 85-92, 2012 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22749591
18.
Co-administration strategy to enhance brain accumulation of vandetanib by modulating P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp1/Abcg2) mediated efflux with m-TOR inhibitors.
Int J Pharm
; 434(1-2): 306-14, 2012 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22633931
19.
Enhanced brain accumulation of pazopanib by modulating P-gp and Bcrp1 mediated efflux with canertinib or erlotinib.
Int J Pharm
; 436(1-2): 127-34, 2012 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22688250
20.
Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals.
Life Sci
; 88(21-22): 959-71, 2011 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-20932495